Header cover image

Danish (OMX) Pharma Industry Analysis

UpdatedSep 23, 2024
DataAggregated Company Financials
Companies4
  • 7D-7.7%
  • 3M-16.8%
  • 1Y33.8%
  • YTD22.5%

Over the last 7 days, the Pharma industry has dropped 1.7%, driven by declines from every company within the industry. This takes the industry's 12 month performance to a gain of 40%. As for the next few years, earnings are expected to grow by 14% per annum.

Industry Valuation and Performance

Has the Danish Pharma Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Tue, 24 Sep 2024DKK 3.9tDKK 283.9bDKK 93.2b41.9x41.4x13.6x
Thu, 22 Aug 2024DKK 4.1tDKK 283.6bDKK 93.0b44.4x43.7x14.3x
Sat, 20 Jul 2024DKK 4.1tDKK 269.3bDKK 92.2b45x44.4x15.2x
Mon, 17 Jun 2024DKK 4.5tDKK 269.3bDKK 92.2b49.2x48.4x16.6x
Wed, 15 May 2024DKK 4.1tDKK 269.1bDKK 92.1b45.4x44.8x15.3x
Fri, 12 Apr 2024DKK 3.9tDKK 257.0bDKK 86.4b46.3x45.6x15.3x
Sun, 10 Mar 2024DKK 4.1tDKK 257.0bDKK 86.4b48.3x47.4x16x
Tue, 06 Feb 2024DKK 3.7tDKK 256.6bDKK 86.6b43.1x42.3x14.3x
Thu, 04 Jan 2024DKK 3.2tDKK 238.8bDKK 78.2b41.7x40.8x13.4x
Sat, 02 Dec 2023DKK 3.2tDKK 238.8bDKK 78.2b41.4x40.5x13.3x
Mon, 30 Oct 2023DKK 3.0tDKK 225.4bDKK 70.1b43.9x42.9x13.3x
Wed, 27 Sep 2023DKK 3.0tDKK 225.4bDKK 70.1b43.2x42.3x13.1x
Fri, 25 Aug 2023DKK 2.9tDKK 225.3bDKK 70.0b43x42x13.1x
Sun, 23 Jul 2023DKK 2.5tDKK 211.8bDKK 63.8b40.6x39.7x12x
Tue, 20 Jun 2023DKK 2.5tDKK 211.8bDKK 63.8b39.7x38.9x11.7x
Thu, 18 May 2023DKK 2.6tDKK 211.8bDKK 63.8b42.2x41.3x12.5x
Sat, 15 Apr 2023DKK 2.6tDKK 199.9bDKK 57.8b59.5x45.6x13.2x
Mon, 13 Mar 2023DKK 2.3tDKK 199.7bDKK 57.8b40.6x39.9x11.5x
Wed, 08 Feb 2023DKK 2.2tDKK 199.1bDKK 57.4b39.3x38.5x11.1x
Fri, 06 Jan 2023DKK 2.2tDKK 189.2bDKK 54.7b41x40.4x11.7x
Sun, 04 Dec 2022DKK 2.1tDKK 189.2bDKK 54.7b38.4x37.9x11x
Tue, 01 Nov 2022DKK 1.9tDKK 178.4bDKK 52.1b36.7x36.6x10.7x
Thu, 29 Sep 2022DKK 1.8tDKK 178.4bDKK 52.1b34.2x34.2x10x
Sat, 27 Aug 2022DKK 1.9tDKK 178.4bDKK 52.1b36.7x36.8x10.8x
Mon, 25 Jul 2022DKK 2.0tDKK 169.5bDKK 50.7b38.6x38.9x11.6x
Wed, 22 Jun 2022DKK 1.8tDKK 169.5bDKK 50.7b35x35.3x10.6x
Fri, 20 May 2022DKK 1.7tDKK 169.5bDKK 50.7b33.6x34x10.2x
Sun, 17 Apr 2022DKK 1.9tDKK 161.0bDKK 49.3b38.6x38.7x11.8x
Tue, 15 Mar 2022DKK 1.7tDKK 161.0bDKK 49.3b33.3x33.5x10.3x
Thu, 10 Feb 2022DKK 1.6tDKK 161.2bDKK 49.8b32.8x32.6x10.1x
Sat, 08 Jan 2022DKK 1.6tDKK 154.9bDKK 48.2b32.8x32.8x10.2x
Mon, 06 Dec 2021DKK 1.7tDKK 154.9bDKK 48.2b34.8x34.8x10.8x
Wed, 03 Nov 2021DKK 1.7tDKK 150.5bDKK 46.4b36.8x36.7x11.3x
Fri, 01 Oct 2021DKK 1.5tDKK 150.5bDKK 46.4b32.1x32.1x9.9x
Price to Earnings Ratio

32.1x


Total Market Cap: DKK 1.5tTotal Earnings: DKK 46.4bTotal Revenue: DKK 150.5bTotal Market Cap vs Earnings and Revenue0%0%0%
Danish Pharma Industry Price to Earnings3Y Average 39.6x202220232024
Current Industry PE
  • Investors are optimistic on the Danish Pharmaceuticals industry, and appear confident in long term growth rates.
  • The industry is trading at a PE ratio of 43.6x which is higher than its 3-year average PE of 39.5x.
  • The 3-year average PS ratio of 12.3x is lower than the industry's current PS ratio of 14.3x.
Past Earnings Growth
  • The earnings for companies in the Pharmaceuticals industry have grown 26% per year over the last three years.
  • Revenues for these companies have grown 24% per year.
  • This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Industry Trends

Which industries have driven the changes within the Danish Healthcare industry?

DK Market-5.04%
Healthcare-7.18%
Pharma-7.67%
Pharma-7.67%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
No data available
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

NOVO B

DKK 832.40

Novo Nordisk

7D

-7.9%

1Y

28.0%

ALK B

DKK 171.60

ALK-Abelló

7D

-3.6%

1Y

113.4%

HLUN B

DKK 44.18

H. Lundbeck

7D

-1.6%

1Y

17.5%

STENO

DKK 2.30

Stenocare

7D

-3.4%

1Y

-34.3%